Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3061 AL 3075

From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson's Disease Treatment?

Vilela C, Araújo B, Soares-Guedes C, Caridade-Silva R, Martins-Macedo J, Teixeira C, Gomes ED, Prudêncio C, Vieira M, Teixeira FG.

Cells. 2024 Apr 30;13(9):770. doi: 10.3390/cells13090770.

The Role of Zinc in the Development of Vascular Dementia and Parkinson's Disease and the Potential of Carnosine as Their Therapeutic Agent

Mizuno D, Kawahara M, Konoha-Mizuno K, Hama R, Ogawara T.

Biomedicines. 2024 Jun 11;12(6):1296. doi: 10.3390/biomedicines12061296.

An update on novel and emerging therapeutic targets in Parkinson's disease

Sawant R, Godad A.

Metab Brain Dis. 2024 Aug;39(6):1213-1225. doi: 10.1007/s11011-024-01390-z. Epub 2024 Jul 27.

The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson's therapeutics

Rubilar JC, Outeiro TF, Klein AD.

Brain. 2024 Aug 1;147(8):2610-2620. doi: 10.1093/brain/awae070.

Current Progress in Aptasensor for Ultra-Low Level Monitoring of Parkinson's Disease Biomarkers

Margiana R, Hammid AT, Ahmad I, Alsaikhan F, Turki Jalil A, Tursunbaev F, Umar F, Romero Parra RM, Fakri Mustafa Y.

Crit Rev Anal Chem. 2024;54(3):617-632. doi: 10.1080/10408347.2022.2091920. Epub 2022 Jun 26.

Neuroimmune Connectomes in the Gut and Their Implications in Parkinson's Disease

Thomasi B, Valdetaro L, Gulbransen B, Tavares-Gomes AL.

Mol Neurobiol. 2024 Apr;61(4):2081-2098. doi: 10.1007/s12035-023-03679-z. Epub 2023 Oct 16.

The Story behind the Mask: A Narrative Review on Hypomimia in Parkinson's Disease

Bianchini E, Rinaldi D, Alborghetti M, Simonelli M, D'Audino F, Onelli C, Pegolo E, Pontieri FE.

Brain Sci. 2024 Jan 22;14(1):109. doi: 10.3390/brainsci14010109.

Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson's Disease

Polgar S, Finkelstein DI, Karimi L.

Cell Transplant. 2024 Jan-Dec;33:9636897241246355. doi: 10.1177/09636897241246355.

Pharmacodynamical research of extracts and compounds in traditional Chinese medicines for Parkinson's disease

Li M, Wang H, Bai Y, Xiong F, Wu S, Bi Q, Qiao Y, Zhang Y, Li X, Feng L, Guo DA.

Fitoterapia. 2024 Sep;177:106086. doi: 10.1016/j.fitote.2024.106086. Epub 2024 Jun 17.

Frankincense: A neuronutrient to approach Parkinson's disease treatment

Calabrese V, Osakabe N, Khan F, Wenzel U, Modafferi S, Nicolosi L, Fritsch T, Jacob UM, Abdelhameed AS, Rashan L.

Open Med (Wars). 2024 Jun 17;19(1):20240988. doi: 10.1515/med-2024-0988. eCollection 2024.

⍺-Synuclein levels in Parkinson's disease - Cell types and forms that contribute to pathogenesis

Sagredo GT, Tanglay O, Shahdadpuri S, Fu Y, Halliday GM.

Exp Neurol. 2024 Sep;379:114887. doi: 10.1016/j.expneurol.2024.114887. Epub 2024 Jul 14.

Environmental pollutants and alpha-synuclein toxicity in Parkinson's disease

Roy S, Kakoty V, Sahebkar A, Md S, Kesharwani P.

Pathol Res Pract. 2024 Nov;263:155605. doi: 10.1016/j.prp.2024.155605. Epub 2024 Sep 24.

Clinical management model for impulse control disorders in Parkinson's disease

Li H, Yang Y, Yang L, Xie A.

CNS Spectr. 2024 Oct 29:1-10. doi: 10.1017/S1092852924000403. Online ahead of print.

Circadian rhythm disruption: a potential trigger in Parkinson's disease pathogenesis

Xu K, Zhang Y, Shi Y, Zhang Y, Zhang C, Wang T, Lv P, Bai Y, Wang S.

Front Cell Neurosci. 2024 Oct 30;18:1464595. doi: 10.3389/fncel.2024.1464595. eCollection 2024.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias